Sansure Biotech Inc. Share Price
Equities
688289
CNE1000043J1
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.76 CNY | -0.45% |
|
-4.45% | +4.49% |
| 12-17 | Sansure Biotech Gets China Nod for Four Testing Kits | MT |
| 11-03 | Sansure Biotech Gets Registration Certificates for Pathogen Detection Kits | MT |
| Capitalization | 11.35B 1.63B 1.39B 1.29B 1.21B 2.25B 148B 2.42B 14.86B 5.87B 70.55B 6.11B 5.99B 257B | P/E ratio 2025 * |
33.9x | P/E ratio 2026 * | 26.3x |
|---|---|---|---|---|---|
| Enterprise value | 11.35B 1.63B 1.39B 1.29B 1.21B 2.25B 148B 2.42B 14.86B 5.87B 70.55B 6.11B 5.99B 257B | EV / Sales 2025 * |
5.97x | EV / Sales 2026 * | 4.88x |
| Free-Float |
46.07% | Yield 2025 * |
2.63% | Yield 2026 * | 2.63% |
| 1 day | -0.45% | ||
| 1 week | -4.45% | ||
| Current month | +4.49% | ||
| 1 month | +3.02% | ||
| 3 months | -2.08% | ||
| 6 months | -7.19% | ||
| Current year | +4.49% |
| 1 week | 19.62 |  | 21.18 |
| 1 month | 18.8 | | 21.36 |
| Current year | 18.89 | | 21.36 |
| 1 year | 17.73 | | 26.36 |
| 3 years | 14.72 | | 26.36 |
| 5 years | 14.72 | | 97.05 |
| 10 years | 14.72 | | 105.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Li Zhong Dai
CEO | Chief Executive Officer | 58 | 07/07/2019 |
Wu Tan
IRC | Investor Relations Contact | 42 | - |
Zhu Peng
DFI | Director of Finance/CFO | 50 | 07/07/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Li Zhong Dai
CHM | Chairman | 58 | 22/04/2008 |
Xia Lin Yu
BRD | Director/Board Member | 47 | - |
Zhu Peng
BRD | Director/Board Member | 50 | 21/02/2020 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +11.03% | 1.04% | 6 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.45% | -4.45% | -0.45% | -13.97% | 1.64B | |
| +2.43% | +6.79% | +213.34% | +262.71% | 14.45B | |
| -0.77% | -5.30% | -6.33% | +6.58% | 14.35B | |
| -1.90% | +2.62% | - | - | 7.56B | |
| -1.42% | -5.43% | -6.56% | +0.23% | 6.54B | |
| -1.51% | +1.31% | -26.99% | -41.58% | 4.74B | |
| +2.54% | -2.37% | -27.98% | +21.06% | 4.26B | |
| -0.54% | -1.34% | -8.05% | -45.47% | 3.04B | |
| +7.46% | +11.36% | +46.22% | -50.98% | 2.6B | |
| Average | +0.65% | -2.08% | +22.90% | +17.32% | 6.58B | |
| Weighted average by Cap. | +0.36% | -2.06% | +54.17% | +67.62% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.9B 273M 233M 216M 203M 377M 24.85B 405M 2.49B 983M 11.81B 1.02B 1B 43.11B | 2.32B 334M 284M 264M 248M 461M 30.38B 495M 3.04B 1.2B 14.44B 1.25B 1.23B 52.71B |
| Net income | 338M 48.56M 41.39M 38.35M 36.07M 67.14M 4.42B 72.02M 443M 175M 2.1B 182M 178M 7.67B | 434M 62.41M 53.19M 49.28M 46.35M 86.27M 5.68B 92.54M 569M 225M 2.7B 234M 229M 9.86B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/01/26 | 19.76 ¥ | -0.45% | 4,692,717 |
| 19/01/26 | 19.85 ¥ | -0.40% | 4,827,966 |
| 16/01/26 | 19.93 ¥ | -1.14% | 5,539,035 |
| 15/01/26 | 20.16 ¥ | -1.90% | 6,209,415 |
| 14/01/26 | 20.55 ¥ | -0.68% | 13,068,830 |
End-of-day quote Shanghai S.E., January 19, 2026
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Annual profits - Rate of surprise
- Stock Market
- Equities
- 688289 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition